scientific-skills/Protocol Design/network-tox-docking-research-planner/SKILL.md
--- name: network-tox-docking-research-planner description: Generates complete network toxicology + molecular docking research designs from a user-provided toxicant and disease/phenotype. Always use this skill when users want to investigate how an environmental toxicant, endocrine disruptor, heavy metal, food contaminant, pharmaceutical residue, or consumer product chemical may contribute to a disease through shared molecular targets, hub genes, pathways, and docking evidence. Trigger for: "netw
npx skillsauth add aipoch/medical-research-skills scientific-skills/Protocol Design/network-tox-docking-research-plannerInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Generates a complete network toxicology + molecular docking study design from a user-provided toxicant and disease/phenotype. Always outputs four workload configurations and a recommended primary plan.
This skill accepts: a toxicant (environmental chemical, endocrine disruptor, heavy metal, food contaminant, pharmaceutical residue, or consumer product chemical) paired with a disease or phenotype, for which the user wants to generate a network toxicology + molecular docking research design.
If the user's request does not involve a toxicant–disease pair for network toxicology research design — for example, asking to execute a STRING query, download GEO datasets, write production code, answer a clinical pharmacology question, or design a non-toxicology study — do not proceed with the workflow. Instead respond:
"Network Toxicology + Molecular Docking Research Planner is designed to generate computational research designs for toxicant–disease mechanism studies. Please provide a toxicant and a disease or phenotype. If you want to run the analysis directly, use a data-execution tool; if you need a different study type, use the appropriate planner skill."
Minimum required input: one toxicant + one disease or phenotype.
If workload is unspecified, default to: Standard as primary · Lite as minimal · Advanced as upgrade.
Read → references/decision-logic.md
Identify: toxicant class · disease type · whether docking is central or supportive · validation feasibility · resource constraints · publication ambition · whether input involves multiple toxicants (→ Pattern F in Step 2).
Read → references/study-patterns.md
Match to one of six canonical design styles (A–F). State which pattern applies and why.
| Pattern | When to use | |---|---| | A. Single Toxicant–Single Disease | Core design, any toxicant + disease pair | | B. Endocrine Disruptor Mechanism | EDC + hormone/metabolic/reproductive disease | | C. Network Tox + Random Dataset Validation | Light GEO expression support layer | | D. PPI Hub Gene + Docking-Centered | Compact publishable hub+docking focus | | E. Publication-Oriented Integrated | Full pipeline, stronger mechanism story | | F. Multi-Toxicant Comparative | 2–3 toxicants + one disease, comparative overlap analysis |
Read → references/configurations.md
Always output all four tiers — except when the user explicitly requests only one tier AND the request is time- or resource-constrained (e.g., "2-week Lite only"). In that case, output the requested tier in full and include a collapsed one-row summary for the other three tiers labeled "Other Configurations (summary only)."
Recommend one tier. Justify the choice.
| Tier | Best for | Workload | Target sources | Docking targets | |---|---|---|---|---| | Lite | Quick launch, skeleton paper | 2–4 wk | 2 | Top 3 | | Standard | Mainstream publication (default) | 4–6 wk | ≥2 | Top 3–5 | | Advanced | Competitive journals | 6–10 wk | ≥3 + harmonization | Top 5 + rationale | | Publication+ | High-impact, multi-layer | 10–16 wk | ≥3 + harmonization | Multi-target comparison |
For each step follow the step-level standard (every step must include):
Step Name / Purpose / Input / Method / Key Parameters / Expected Output / Failure Points / Alternative Methods
Draw modules from → references/modules.md
Read → references/output-standard.md
Every response must contain all nine parts (A–I):
references/output-standard.md Part G)Plans must address these patterns when relevant:
| Pattern | Requirement | |---|---| | Toxicant target prediction + disease target intersection | Required | | PPI + hub gene discovery (STRING + Cytoscape + CytoHubba) | Required | | GO / KEGG enrichment | Required | | Docking of top hub genes (CB-Dock2 or AutoDock Vina) | Required | | GEO / random expression validation | Recommended (Standard+, when dataset available) | | Endocrine/metabolic pathway interpretation | Recommended (if biologically relevant) | | Multiple target-prediction databases | Required (Standard+) | | Integrated mechanism model figure | Required | | Wet-lab follow-up suggestion | Optional (Publication+) |
references/modules.md before proceeding.| File | When to read |
|---|---|
| references/decision-logic.md | Step 1 — infer toxicant class, docking role, constraints |
| references/study-patterns.md | Step 2 — select A–F canonical pattern |
| references/configurations.md | Step 3 — generate four tiers + comparison table |
| references/modules.md | Step 4 — module details, tool library, docking target rules, zero-overlap recovery |
| references/output-standard.md | Step 5 — mandatory Parts A–I structure + evidence layer tables |
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.